Idiopathic pulmonary fibrosis (IPF) is a lethal form of idiopathic diffuse lung disorders for
which no current treatment is effective. The aim of the present study was to systematically …

Randomised controlled clinical trials are fundamental in medicine to develop new effective
drugs and new therapeutic regimens and are the strength of evidence-based medicine …

Recently updated guidelines have provided revised recommendations, based on the
GRADE criteria, for the diagnosis and pharmacological and non-pharmacological …

The long-standing need to determine an effective medical treatment regimen with clinically
significant and relevant end-points to improve outcome for patients with idiopathic …

Despite multiple clinical trials, there is no strong, definitive evidence in favor of any agent to
treat IPF. On the other hand, the placebo arms of these large trials have provided us with …

Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive lung disease in most cases,
and effective treatment is still lacking. This review examines the current status of treatment …

Idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic interstitial
pneumonias. Despite multiple recent clinical trials, there is no strong evidence supporting a …

After introduction of the new international guidelines on idiopathic pulmonary fibrosis (IPF) in
2011, we investigated clinical management practices for patients with IPF according to …

Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating, scarring lung disease
with a worse prognosis than some cancers. The incidence of IPF is increasing and while …

Idiopathic pulmonary fibrosis (IPF) is a rare disease characterized by chronic, progressive,
and irreversible interstitial lung fibrosis of unknown cause [1, 2]. Main symptoms and signs …